CELZ
Price
$3.31
Change
+$0.06 (+1.85%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
8.39M
IMRN
Price
$1.94
Change
-$0.00 (-0.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
13.45M
68 days until earnings call
Interact to see
Advertisement

CELZ vs IMRN

Header iconCELZ vs IMRN Comparison
Open Charts CELZ vs IMRNBanner chart's image
Creative Medical Technology Holdings
Price$3.31
Change+$0.06 (+1.85%)
Volume$201
Capitalization8.39M
Immuron
Price$1.94
Change-$0.00 (-0.00%)
Volume$505
Capitalization13.45M
CELZ vs IMRN Comparison Chart in %
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. IMRN commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Buy and IMRN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CELZ: $3.25 vs. IMRN: $1.93)
Brand notoriety: CELZ and IMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 38% vs. IMRN: 59%
Market capitalization -- CELZ: $8.39M vs. IMRN: $13.45M
CELZ [@Biotechnology] is valued at $8.39M. IMRN’s [@Biotechnology] market capitalization is $13.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileIMRN’s FA Score has 1 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • IMRN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CELZ and IMRN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 6 TA indicator(s) are bullish while IMRN’s TA Score has 6 bullish TA indicator(s).

  • CELZ’s TA Score: 6 bullish, 4 bearish.
  • IMRN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, IMRN is a better buy in the short-term than CELZ.

Price Growth

CELZ (@Biotechnology) experienced а -7.41% price change this week, while IMRN (@Biotechnology) price change was +6.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

IMRN is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRN($13.4M) has a higher market cap than CELZ($8.39M). CELZ YTD gains are higher at: 40.693 vs. IMRN (13.529). CELZ has higher annual earnings (EBITDA): -5.81M vs. IMRN (-7.35M). IMRN has more cash in the bank: 7.74M vs. CELZ (6.54M). IMRN has higher revenues than CELZ: IMRN (6.54M) vs CELZ (6K).
CELZIMRNCELZ / IMRN
Capitalization8.39M13.4M63%
EBITDA-5.81M-7.35M79%
Gain YTD40.69313.529301%
P/E RatioN/AN/A-
Revenue6K6.54M0%
Total Cash6.54M7.74M85%
Total Debt2.74MN/A-
FUNDAMENTALS RATINGS
CELZ vs IMRN: Fundamental Ratings
CELZ
IMRN
OUTLOOK RATING
1..100
694
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4957
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (26) in the Biotechnology industry is somewhat better than the same rating for CELZ (79) in the null industry. This means that IMRN’s stock grew somewhat faster than CELZ’s over the last 12 months.

IMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CELZ (100) in the null industry. This means that IMRN’s stock grew similarly to CELZ’s over the last 12 months.

IMRN's SMR Rating (97) in the Biotechnology industry is in the same range as CELZ (98) in the null industry. This means that IMRN’s stock grew similarly to CELZ’s over the last 12 months.

CELZ's Price Growth Rating (49) in the null industry is in the same range as IMRN (57) in the Biotechnology industry. This means that CELZ’s stock grew similarly to IMRN’s over the last 12 months.

CELZ's P/E Growth Rating (55) in the null industry is somewhat better than the same rating for IMRN (100) in the Biotechnology industry. This means that CELZ’s stock grew somewhat faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELZIMRN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOGI108.51-0.28
-0.26%
Logitech International SA
DAN19.70-0.13
-0.66%
Dana
DRCT0.36N/A
-0.77%
Direct Digital Holdings
BLZE9.79-0.67
-6.41%
Backblaze
STEC1.27-0.16
-11.19%
Santech Holdings Limited

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with LABFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
+4.50%
LABFF - CELZ
35%
Loosely correlated
N/A
RARE - CELZ
33%
Loosely correlated
-3.27%
MREO - CELZ
32%
Poorly correlated
-1.67%
WVE - CELZ
30%
Poorly correlated
-1.04%
CRSP - CELZ
30%
Poorly correlated
-1.20%
More

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with LABFF. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
+0.52%
LABFF - IMRN
81%
Closely correlated
N/A
MNMD - IMRN
44%
Loosely correlated
-0.51%
VYGR - IMRN
26%
Poorly correlated
-3.76%
CELZ - IMRN
25%
Poorly correlated
+4.50%
TCRX - IMRN
24%
Poorly correlated
-3.26%
More